Shaikh Nawazish, Kumar Vinod, Ramachandran Aiswarya, Venkatesh Ramesh, Tekchandani Uday, Tyagi Mudit, Jayadev Chaitra, Dogra Mohit, Chawla Rohan
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi, India.
Anant Bajaj Retina Institute, LVPEI, Hyderabad, India.
Indian J Ophthalmol. 2024 Dec 1;72(12):1704-1713. doi: 10.4103/IJO.IJO_30_24. Epub 2024 Aug 14.
Microvascular complications of diabetic retinopathy (DR) may require surgical intervention in the form of vitrectomy. Since its inception, diabetic vitrectomy has evolved with introduction of better instruments, newer techniques, and smaller port sizes. Common indications for diabetic vitrectomy include nonresolving vitreous hemorrhage, tractional retinal detachment, epiretinal membrane, progression of fibrovascular membranes despite laser therapy, recalcitrant diabetic macular edema, and neovascular glaucoma. Preoperative systemic stabilization is essential prior to planning surgery. Surgical techniques commonly used in diabetic vitrectomy are segmentation, delamination, and rarely en-bloc dissection. Modification in surgical techniques such as chandelier-assisted bimanual dissection and pharmacological adjuvants improve surgical outcomes in these patients. Prognosis in these patients could be improved with early intervention. Studies evaluating the outcome of vitrectomy in patients with early proliferative DR are required to understand the appropriate time of intervention in patients. Treatment aimed at arresting the progression of DR and gene therapy are avenues that need further evaluation. The following review will focus on covering the epidemiology of DR, indications of vitrectomy, preoperative considerations, surgical procedures of diabetic vitrectomy, methods of membrane dissection, pharmacological adjuvants to vitrectomy, outcomes of diabetic vitrectomy, and future directions of diabetic vitrectomy.
糖尿病视网膜病变(DR)的微血管并发症可能需要以玻璃体切除术的形式进行手术干预。自开展以来,糖尿病玻璃体切除术随着更好的器械、更新的技术以及更小的切口尺寸的引入而不断发展。糖尿病玻璃体切除术的常见适应证包括无法消退的玻璃体积血、牵拉性视网膜脱离、视网膜前膜、尽管进行了激光治疗但纤维血管膜仍进展、顽固性糖尿病黄斑水肿以及新生血管性青光眼。在计划手术前,术前全身状况稳定至关重要。糖尿病玻璃体切除术中常用的手术技术是分割、分层,很少进行整块切除。诸如吊灯辅助双手操作剥离等手术技术的改进以及药物辅助手段可改善这些患者的手术效果。早期干预可改善这些患者的预后。需要开展研究评估早期增殖性DR患者玻璃体切除术的效果,以了解患者的合适干预时机。旨在阻止DR进展的治疗方法和基因治疗是需要进一步评估的途径。以下综述将重点涵盖DR的流行病学、玻璃体切除术的适应证、术前注意事项、糖尿病玻璃体切除术的手术步骤、膜剥离方法、玻璃体切除术的药物辅助手段、糖尿病玻璃体切除术 的效果以及糖尿病玻璃体切除术的未来方向。